| Document |
Document Title |
|
JP3078053B2 |
|
|
JP2000510464A |
The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
|
|
JP3061644B2 |
1-Phenyl pyrazole-3-carboxamides of formula (I), their salts, quaternary ammonium salts formed with tertiary amines, and their solvates, are new. R1 = TCN, C(NH2)=NOH, C(=NOH)NH(CH2)rNR5R6, TC(NR12R13)=NR14, C(NH2)=NO(CH2)rNR5R6, TCONRaR...
|
|
JP2000506497A |
Indane compounds of general formulas (7) and (8) and their pharmaceutical use particularly to achieve smooth muscle relaxing activity and/or mast cell stabilizing activity and/or anti-inflammatory activity as described, wherein in formul...
|
|
JP2000505803A |
This invention provides perfluoro(alkoxycycloalkane) carbonyl fluoride compounds wherein, pendant from the fluorinated ring, are from 2 to 5 perfluoroalkoxy groups having from 1 to 4, preferably 1 to 2, carbon atoms with the proviso that...
|
|
JP3033825B2 |
To enable Zoysia japonica to extensively grow and to be maintained through such means as to raise summer tolerance considered as a drawback of bentosiba typical of cold district type among others, along with its cold resistance and disea...
|
|
JP3032987B2 |
PCT No. PCT/EP91/01434 Sec. 371 Date Apr. 16, 1993 Sec. 102(e) Date Apr. 16, 1993 PCT Filed Jul. 31, 1991 PCT Pub. No. WO92/02483 PCT Pub. Date Feb. 29, 1992.Racemates are obtained from non-racemic 3-oxocyclopentane or 3-oxocyclohexane c...
|
|
JP2000086575A |
To cheaply and efficiently produce the subject compound useful as a raw material for a medicine, a raw material for a cosmetic, or the like by subjecting quinic acids included in a naturally occurring material to hydrolysis or alcoholysi...
|
|
JP2000072648A |
To obtain a skin whitening agent, showing a demelanizing function, and excellent hypochromic and skin-whitening effects functions against sunburning-caused pigmentation, fleckles and chloasmata, and also excellent in safety, by including...
|
|
JP2000502328A |
Indane compounds of general formulas (7) and (8) and their pharmaceutical use particularly to achieve smooth muscle relaxing activity and/or mast cell stabilizing activity and/or anti-inflammatory activity as described, wherein in formul...
|
|
JP2000502072A |
Indane compounds of general formulas (7) and (8) and their pharmaceutical use particularly to achieve smooth muscle relaxing activity and/or mast cell stabilizing activity and/or anti-inflammatory activity as described, wherein in formul...
|
|
JPH11349583A |
To produce a quinic acid derivative useful as a pharmaceutical intermediate effectively at a low cost by converting a quinic acid component of a crude quinic acid containing an inorganic salt in a large amount extracted from an extractio...
|
|
JP2966978B2 |
Hydrophobic casting moulds are treated with electrical discharge, such as corona discharge, to provide enhanced compatibility with hydrophilic objects introduced into the mould, without interfering with the release properties of the moul...
|
|
JPH11240851A |
To obtain the subject new compound useful as an optical material having excellent heat resistance, transparency and moisture resistance. This compound is shown by formula I ((n) is 1 or 2; R1 to R3 are each H or a 1-6C hydrocarbon). The ...
|
|
JPH11508559A |
A process for the preparation of (+)-2-amino-bicycloÄ3.1.0Ü-hexane-2-6-dicarboxylic acid, or a pharmaceutically acceptable salt thereof, which comprises hydrolysing (-)-2-spiro-5'-hydantoinbicycloÄ3.1.0Ühexane-6-carboxylic acid or a ...
|
|
JPH11180930A |
To obtain the subject compound by reacting racemic-trans- cyclobutanedicarboxylic acids with an optically active amine to deposit either one diastereomeric salt and subjecting the salt to acid decomposition to directly optically resolve ...
|
|
JP2907144B2 |
There is provided a photoresist including (a) a resin composed of a polymer having a compound represented with the following general formula [1] within a structural unit thereof, and (b) a photo acid generator. [1] wherein R1 represents ...
|
|
JPH11140014A |
To provide a process for separating expensive quinic acid useful as a food additive, industrial material, pharmaceutical raw material and cosmetic material from a raw material liquid in high efficiency in purified state. This process com...
|
|
JP2895462B2 |
An enantioselective process for preparing trans or cis hemicaron aldehyde derivatives, starting with an alpha-beta unsaturated ester derived from glyceraldehyde acetonide, by the action of a cyclopropanation agent, as well as new interme...
|
|
JPH11130713A |
To obtain the subject new compound useful as an agent for preventing and treating diabetic complications and as an aldose reductase inhibitor. A compound of formula I [R1 and R2 are each hydroxy, a (aryl-substituted) lower alkoxy or a ha...
|
|
JPH11106360A |
To obtain the subject new compound useful as a raw material for electroconductive polymers, photographic photo-sensitive materials, fluorescent materials, transparent resin coatings for organic glasses, optical materials for optical fibe...
|
|
JP2883297B2 |
To obtain the subject novel compound, which affect certain excitatory amino acid receptors and are useful for treatment of neurological and psychiatric disorders. This compound is shown by formula I [X is (CH2)n; R2 is CO2R4 when R3 is H...
|
|
JP2880670B2 |
The invention relates to the use of carnosic acid for the production of a composition intended for preventing or treating cancer and for treating herpes.
|
|
JP2867257B2 |
The invention provides a process for the preparation of fungicidally active cyclopentene derivatives of the general formula cyclopentane derivatives of the general formula and cyclohexane derivatives of the general formula in which n, R,...
|
|
JP2863786B2 |
The present invention is an oxidative process for the conversion of 21-unsaturated progesterones (I) to the corresponding 3,5-secoandrost-5-one-3,17 beta -dioic acids (II) by use of either ozone or an oxidizing agent, which are useful in...
|
|
JP2864698B2 |
|
|
JP2863175B2 |
An enantioselective process for preparing trans or cis hemicaron aldehyde derivatives, starting with an alpha-beta unsaturated ester derived from glyceraldehyde acetonide, by the action of a cyclopropanation agent, as well as new interme...
|
|
JP2864491B2 |
|
|
JPH1149718A |
To obtain the subject new derivative useful as a therapeutic agent for the central neuropathy or peripheral neuropathy. This derivative is represented by formula I (A-ring has one double bond conjugated with oxo group; X is O, S or the l...
|
|
JPH1121267A |
To obtain the subject compounds in high yield, high purity and low in cost useful as intermediates of medicines and agrochemicals by reacting quinic acid derivatives with reagents having dehydrating capability. The (-)-shikimic acid prec...
|
|
JP2848375B2 |
To obtain the subject derivative, an 1,3,5-triphenylpyrazolyl derivative, having arachidonic acid metabolic route-inhibitory activity, and useful as e.g. an agent for mitigating inflammation, asthma, anaphylaxis, myocardial ischemia, der...
|
|
JPH10330266A |
To obtain a composition having activity for enhancing insulin action and differentiation-inducing activity by including a compound having lanostane skeleton or 3,4-secolanostane skeleton as an active ingredient. This composition has at l...
|
|
JP2835731B2 |
1,4-disubstituted piperidinyl compounds of formula I useful as antiarrhythmics, analgesics, and serotonin 5HT2 antagonists.
|
|
JPH10316609A |
To easily produce the subject compound that is useful as a synthetic starting material for 2-norbonanone to be used as a synthetic starting material of a variety of pharmaceuticals and agrochemicals by using di-substituted methyldioxolan...
|
|
JP2831358B2 |
An enantioselective process for the preparation of hemicaronic aldehyde with a cis or trans structure and novel intermediates.
|
|
JP2828295B2 |
Pentacyclic triterpenoid compounds such as alpha -boswellic acid and its acetate, beta -boswellic acid and its acetate, which have an inhibitory effect on topoisomerase I and topoisomerase II, are disclosed. Compositions based on the pen...
|
|
JPH10511388A |
PCT No. PCT/US95/13319 Sec. 371 Date Jun. 23, 1997 Sec. 102(e) Date Jun. 23, 1997 PCT Filed Oct. 10, 1995 PCT Pub. No. WO96/20156 PCT Pub. Date Jul. 4, 1996The present invention relates to novel 3,3-(disubstituted)cyclohexan-1-carboxylat...
|
|
JPH10511398A |
PCT No. PCT/US95/16857 Sec. 371 Date Oct. 6, 1997 Sec. 102(e) Date Oct. 6, 1997 PCT Filed Dec. 21, 1995 PCT Pub. No. WO96/19990 PCT Pub. Date Jul. 4, 1996The present invention relates to novel 4,4-(disubstituted)cyclohexan-1-carboxylate ...
|
|
JPH10511392A |
(57) [Summary] The present invention relates to novel 4,4- (disubstituted) cyclohexane-1-carboxylate dimers and related compounds, pharmaceutical compositions comprising these compounds, and therapeutic and tumor necrosis factors for all...
|
|
JP2809620B2 |
To provide the subject new compound useful as an inert fluid. This compound is expressed by the formula I (Z is COOCH3, COOC2H5 or COOC2H4OCH3), e.g. dimethyl 1,3-perfluorocyclohexanedicarboxylate of the formula II. The objective compoun...
|
|
JPH10510656A |
Compounds, methods and compositions are provided for inducing natriuresis in a mammal. Methods for isolating and synthesizing the natriuretic compounds are also provided. Therapeutic methods using the natriuretic compounds are also provi...
|
|
JP2808322B2 |
The invention provides a process for the preparation of fungicidally active cyclopentene derivatives of the general formula cyclopentane derivatives of the general formula and cyclohexane derivatives of the general formula in which n, R,...
|
|
JPH10509959A |
The object of the present invention is to provide asiatic acid derivatives, its pharmaceutically acceptable salts or esters. Asiatic acid, its trisaccharide asiaticoside and mddecassic acid, extracted from Centella asiatica have been use...
|
|
JPH10509146A |
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The presently claimed compounds have the generalized formula in which each ...
|
|
JP2790479B2 |
Compounds of the general formula A- @-B wherein A is a bicyclic 1-one-2-ene-3-ol-2-yl residue; B is an aryl or heteroaryl group optionally bearing substituents; and salts, enolethers and enolesters thereof, and methods of producing such ...
|
|
JP2788657B2 |
|
|
JP2788427B2 |
PURPOSE: To provide a method for recovering quinic acid in high efficiency and purity from a stock liquid containing sodium sulfate and quinic acid, dispensing with the marine disposal of a waste liquid discharged in the production of ga...
|
|
JP2774381B2 |
|
|
JPH10182546A |
To obtain a new azulene derivative having excellent antiinflammatory, antipyretic, analgesic, and antarthritic actions and little in side effects such as gastrointestinal disorders. An azulene derivative of formula I [R1 is a (substitute...
|
|
JPH10506383A |
Compounds, methods and compositions are provided for inducing natriuresis in a mammal. Methods for isolating and synthesizing the natriuretic compounds are also provided. Therapeutic methods using the natriuretic compounds are also provi...
|
